11 results
20-F/A
2018 FY
IFRX
InflaRx N.V.
29 Mar 19
Annual report (foreign) (amended)
4:23pm
on March 23, 2010, includes a subtitle called the Biologics Price Competition and Innovation Act of 2009. That Act created an approval pathway authorizing … of therapeutic innovation, the applicant may request an accelerated assessment procedure pursuant to Article 14(9) of Regulation (EC) 726/2004. Under
6-K
EX-99.1
dgdrcl9xhqb5zk24za
28 Mar 19
InflaRx Full Year 2018 Financial & Operating Results
8:48am
6-K
EX-99.1
9pg5tc6dzc84ses5euw
5 Jun 18
Current report (foreign)
12:00am
424B4
yhz 3euxpa4tef0q
7 May 18
Prospectus supplement with pricing info
4:47pm
F-1
5v47guxetc
2 May 18
Registration statement (foreign)
7:10am
20-F
sd538aehn 25zxyl6
29 Mar 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next